Bovine Renal Cortex Extract

Bovine renal cortex extract is a glandular supplement derived from cattle kidney cortex containing PTH-sensitive adenylate cyclase and D-aspartate oxidase. The extract's PTH-sensitive adenylate cyclase can stimulate cyclic AMP production in laboratory studies.

Origin & History

Bovine Renal Cortex Extract is derived from the outer region (cortex) of cow (Bos taurus) kidneys, typically obtained through tissue extraction methods including homogenization, plasma membrane purification, or detergent dispersion (e.g., Triton X-100). The extract contains membrane proteins, enzymes like D-aspartate oxidase, and parathyroid hormone (PTH)-sensitive adenylate cyclase, though no commercial supplement standardization exists.

Historical & Cultural Context

No evidence of historical or traditional medicinal use for bovine renal cortex extract was found in any traditional medicine systems. All references are limited to 20th-century physiological and biochemical research on beef kidney extracts for laboratory purposes.

Health Benefits

• No human health benefits documented - all available research consists of in vitro biochemical studies only
• Contains PTH-sensitive adenylate cyclase which stimulates cyclic AMP production (4-fold purification increase noted in vitro)
• Source of peroxisomal enzyme D-aspartate oxidase (EC 1.4.3.1) found in subcellular fractions
• May contain membrane proteins with 40% protein extraction yield via Triton X-100 method
• No clinical evidence exists for any therapeutic applications in humans

How It Works

Bovine renal cortex extract contains PTH-sensitive adenylate cyclase, which responds to parathyroid hormone by catalyzing the conversion of ATP to cyclic adenosine monophosphate (cAMP). In vitro studies show this enzyme can increase cAMP production with a 4-fold purification enhancement. The extract also provides D-aspartate oxidase (EC 1.4.3.1), a peroxisomal enzyme that catalyzes the oxidation of D-aspartate amino acid.

Scientific Research

No human clinical trials, RCTs, or meta-analyses were identified for bovine renal cortex extract as a supplement. Available research consists entirely of preclinical biochemical studies, such as PTH binding to detergent-dispersed bovine kidney cortex membranes (PMID: 14130, J Biol Chem 1977) and enzyme assays for D-aspartate oxidase.

Clinical Summary

No human clinical trials have been conducted on bovine renal cortex extract supplementation. All available research consists solely of in vitro biochemical studies examining enzyme activity and purification methods. The documented effects on PTH-sensitive adenylate cyclase and D-aspartate oxidase activity have only been demonstrated in laboratory cell culture systems. Without human studies, the clinical relevance and therapeutic potential remain entirely unestablished.

Nutritional Profile

Bovine renal cortex extract is a protein-based concentrate derived from the cortical region of bovine kidneys. Primary macronutrient is protein, typically comprising 60-85% of dry weight depending on extraction method, with ~40% extraction yield reported using membrane protein isolation protocols. Protein fractions include enzymatically active membrane-bound proteins (notably PTH-sensitive adenylate cyclase complex) and peroxisomal enzymes including D-aspartate oxidase (EC 1.4.3.1). Amino acid composition reflects renal cortex tissue: rich in glutamic acid, aspartic acid, leucine, and lysine consistent with mammalian organ tissue protein profiles. Contains endogenous cyclic AMP pathway signaling proteins capable of 4-fold purification concentration. Micronutrient content mirrors renal cortex tissue: expected to contain zinc (cofactor for renal enzymes, estimated 2-5 mg/100g dry weight), selenium (concentrated in kidney tissue, estimated 50-150 mcg/100g), copper, and iron in heme and non-heme forms. B-vitamins inherent to organ tissue including B12 (estimated 10-30 mcg/100g), riboflavin (B2), and niacin are probable constituents. Phospholipid content from membrane protein fractions (phosphatidylcholine, phosphatidylethanolamine) is expected given membrane protein extraction context. Bioavailability: oral bioavailability of intact signaling proteins and enzymes (adenylate cyclase, D-aspartate oxidase) is considered negligible due to gastric proteolysis; peptide fragments and free amino acids would represent primary absorbable fractions. No clinically validated bioavailability data exists for this specific extract in humans.

Preparation & Dosage

No clinically studied dosage ranges exist for bovine renal cortex extract in humans. All available research used tissue homogenates or membrane preparations for in vitro studies without any quantified oral or in vivo doses for supplementation. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

No synergistic ingredients identified due to lack of clinical research

Safety & Interactions

Safety data for bovine renal cortex extract supplementation is unavailable due to the absence of human studies. Potential concerns include allergic reactions to bovine proteins and contamination risks from animal-derived materials. No drug interactions, contraindications, or pregnancy safety guidelines have been established. Individuals with kidney disease or those taking medications affecting renal function should consult healthcare providers before use.